{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:53:40Z","timestamp":1761947620492},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00520-010-0868-z","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T20:31:23Z","timestamp":1270067483000},"page":"425-430","source":"Crossref","is-referenced-by-count":18,"title":["Zoledronic acid and atrial fibrillation in cancer patients"],"prefix":"10.1007","volume":"19","author":[{"given":"Cagatay","family":"Arslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Dizdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem","family":"S. Dede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Harputluoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadri","family":"Altundag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"868_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2796.2008.02065.x","volume":"265","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen B, Eiken P, Brixen K (2009) Atrial fibrillation in fracture patients treated with oral bisphosphonates. J Intern Med 265:581\u2013592","journal-title":"J Intern Med"},{"key":"868_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archinte.168.8.826","volume":"168","author":"SR Heckbert","year":"2008","unstructured":"Heckbert SR, Li G, Cummings SR et al (2008) Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 168:826\u2013831","journal-title":"Arch Intern Med"},{"key":"868_CR3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"868_CR4","first-page":"2394","volume":"9","author":"A Ibrahim","year":"2003","unstructured":"Ibrahim A, Scher N, Williams G et al (2003) Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Clin Cancer Res 9:2394\u20132399","journal-title":"Clin Cancer Res"},{"key":"868_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.327.7406.89","volume":"327","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Akesson K (2003) Preventing fractures in elderly people. Bmj 327:89\u201395","journal-title":"Bmj"},{"key":"868_CR6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"868_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.39507.551644.BE","volume":"336","author":"HT Sorensen","year":"2008","unstructured":"Sorensen HT, Christensen S, Mehnert F et al (2008) Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. Bmj 336:813\u2013816","journal-title":"Bmj"},{"key":"868_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/gme.0b013e3181b34749","volume":"17","author":"WF Huang","year":"2009","unstructured":"Huang WF, Tsai YW, Wen YW et al (2009) Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. Menopause 17:57\u201363","journal-title":"Menopause"},{"key":"868_CR9","doi-asserted-by":"crossref","first-page":"e4720","DOI":"10.1371\/journal.pone.0004720","volume":"4","author":"A Grosso","year":"2009","unstructured":"Grosso A, Douglas I, Hingorani A et al (2009) Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. PLoS One 4:e4720","journal-title":"PLoS One"},{"key":"868_CR10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjcard.2008.11.037","volume":"103","author":"TJ Bunch","year":"2009","unstructured":"Bunch TJ, Anderson JL, May HT et al (2009) Relation of bisphosphonate therapies and risk of developing atrial fibrillation. Am J Cardiol 103:824\u2013828","journal-title":"Am J Cardiol"},{"key":"868_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983\u2013988","journal-title":"Stroke"},{"key":"868_CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-8703(83)90208-9","volume":"106","author":"WB Kannel","year":"1983","unstructured":"Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 106:389\u2013396","journal-title":"Am Heart J"},{"key":"868_CR13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.271.11.840","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Jama 271:840\u2013844","journal-title":"Jama"},{"key":"868_CR14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2007.12.078","volume":"128","author":"M Lainscak","year":"2008","unstructured":"Lainscak M, Dagres N, Filippatos GS et al (2008) Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol 128:311\u2013315","journal-title":"Int J Cardiol"},{"key":"868_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11739-008-0124-4","volume":"3","author":"S Guzzetti","year":"2008","unstructured":"Guzzetti S, Costantino G, Vernocchi A et al (2008) First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation. Intern Emerg Med 3:227\u2013231","journal-title":"Intern Emerg Med"},{"key":"868_CR16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"868_CR17","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung MK, Martin DO, Sprecher D et al (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886\u20132891","journal-title":"Circulation"},{"key":"868_CR18","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1161\/01.CIR.0000028399.42411.13","volume":"106","author":"S Guzzetti","year":"2002","unstructured":"Guzzetti S, Costantino G, Fundaro C (2002) Systemic inflammation, atrial fibrillation, and cancer. Circulation 106:e40, author reply e40","journal-title":"Circulation"},{"key":"868_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10350-004-6516-2","volume":"46","author":"FP Wu","year":"2003","unstructured":"Wu FP, Sietses C, von Blomberg BM et al (2003) Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 46:147\u2013155","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 1","key":"868_CR20","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1111\/j.1540-8159.2005.00024.x","volume":"28","author":"CW Siu","year":"2005","unstructured":"Siu CW, Tung HM, Chu KW et al (2005) Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Pacing Clin Electrophysiol 28(Suppl 1):S120\u2013123","journal-title":"Pacing Clin Electrophysiol"},{"key":"868_CR21","first-page":"1124","volume-title":"Cecil textbook of medicine","author":"HS Rugo","year":"2004","unstructured":"Rugo HS (2004) Paraneoplastic syndromes and other non-neoplastic effects of cancer. In: Goldman L, Ausiello D (eds) Cecil textbook of medicine, 22nd edn. Saunders, Philedelphia, pp 1124\u20131131","edition":"22"},{"key":"868_CR22","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2004.08.053","volume":"44","author":"CS Hooft van der","year":"2004","unstructured":"van der Hooft CS, Heeringa J, van Herpen G et al (2004) Drug-induced atrial fibrillation. J Am Coll Cardiol 44:2117\u20132124","journal-title":"J Am Coll Cardiol"},{"key":"868_CR23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","volume":"166","author":"CS Hooft van der","year":"2006","unstructured":"van der Hooft CS, Heeringa J, Brusselle GG et al (2006) Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 166:1016\u20131020","journal-title":"Arch Intern Med"},{"key":"868_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11523-009-0112-2","volume":"4","author":"E Azambuja de","year":"2009","unstructured":"de Azambuja E, Bedard PL, Suter T, Piccart-Gebhart M (2009) Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Target Oncol 4:77\u201388","journal-title":"Target Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0868-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-010-0868-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0868-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:59Z","timestamp":1559095319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-0868-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-0868-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}